According to Bayer's latest financial reports the company has $8.41 Billion USD in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2024-12-31 | $8.41 B | -28.09% |
2023-12-31 | $11.70 B | 7.46% |
2022-12-31 | $10.89 B | 24.26% |
2021-12-31 | $8.76 B | -40.04% |
2020-12-31 | $14.61 B | 141.44% |
2019-12-31 | $6.05 B | 1.41% |
2018-12-31 | $5.96 B | -45.32% |
2017-12-31 | $10.91 B | 91.34% |
2016-12-31 | $5.70 B | 144.86% |
2015-12-31 | $2.33 B | -6.86% |
2014-12-31 | $2.50 B | 0.64% |
2013-12-31 | $2.48 B | -7.74% |
2012-12-31 | $2.69 B | -12.08% |
2011-12-31 | $3.06 B | -40.12% |
2010-12-31 | $5.11 B | 15.54% |
2009-12-31 | $4.42 B | 16.16% |
2008-12-31 | $3.81 B | -8.86% |
2007-12-31 | $4.18 B | 6.26% |
2006-12-31 | $3.93 B | -5.58% |
2005-12-31 | $4.17 B | -14.5% |
2004-12-31 | $4.87 B | 35.59% |
2003-12-31 | $3.59 B | 332.01% |
2002-12-31 | $0.83 B | 22.13% |
2001-12-31 | $0.68 B | 2.54% |
2000-12-31 | $0.66 B | |
1998-12-31 | $2.04 B |